Table 3.
Regression analysis of laboratory and pulmonary function parameters in Group 2 (10 mg montelukast) and Group 3 (20 mg montelukast)
| Unstandardized B | Coefficients std. error | Standardized coefficient β | t | p | 95% CI, lower bound | 95% CI, upper bound | |
|---|---|---|---|---|---|---|---|
| Δ Ferritin | 0.000 | 0.000 | 0.102 | 1.075 | 0.284 | 0.000 | 0.001 |
| Δ Fibrinogen | 0.001 | 0.000 | 0.189 | 1.963 | 0.05 | 0.000 | 0.001 |
| Δ D‐dimer | 1.926e−5 | 0.000 | 0.02 | 0.251 | 0.803 | 0.000 | 0.000 |
| Δ CRP | −0.002 | 0.001 | −0.177 | −1.572 | 0.119 | −0.004 | 0.000 |
| Δ LDH | 0.000 | 0.000 | −0.034 | −0.359 | 0.721 | −0.001 | 0.001 |
| Δ FVC | 0.006 | 0.099 | 0.008 | 0.061 | 0.952 | −0.190 | 0.202 |
| Δ FEV1 | −0.006 | 0.136 | −0.007 | −0.041 | 0.967 | −0.275 | 0.264 |
| Δ PEF25–75 | 0.264 | 0.064 | 0.495 | 4.092 | 0.001 | 0.136 | 0.392 |
Abbreviations: Δ, difference between admission and Day 5 of treatment; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; LDH, lactate dehydrogenase; PEF, peak expiratory flow.